The hyperactivation of the PI3K pathway is a characteristic seen in many cancers.33 It is responsible for the regulation of cell survival, cell cycle progression, and cellular growth.33 Of interest, the majority of TNBCs have a genomic aberration in the PI3K/AKT pathway, suggesting this pathway as a precision medicine target. This evidence concerns the gene PIK3CG and cancer.